chloroquin
amin
acidotrop
form
quinin
synthesis
germani
bayer
emerg
approxim
year
ago
effect
substitut
natur
quinin
quinin
compound
found
bark
cinchona
tree
nativ
peru
previou
drug
choic
malaria
decad
chloroquin
frontlin
drug
treatment
prophylaxi
malaria
one
prescrib
drug
worldwid
chloroquin
drug
hydroxychloroquin
belong
molecular
famili
hydroxychloroquin
differ
chloroquin
presenc
hydroxyl
group
end
side
chain
n
ethyl
substitu
molecul
avail
oral
administr
form
hydroxychloroquin
sulfat
hydroxychloroquin
pharmacokinet
similar
chloroquin
rapid
gastrointestin
absorpt
renal
elimin
howev
clinic
indic
toxic
dose
drug
slightli
differ
malaria
indic
chloroquin
high
dose
short
period
time
due
toxic
high
dose
low
dose
long
period
time
hydroxychloroquin
report
activ
chloroquin
plasmodium
falciparum
malaria
less
toxic
much
less
activ
chloroquin
chloroquineresist
p
falciparum
owe
physicochem
properti
advantag
hydroxychloroquin
use
high
dose
long
period
good
toler
unfortun
efficaci
chloroquin
gradual
declin
due
continu
emerg
chloroquineresist
p
falciparum
strain
chloroquin
also
utilis
treatment
autoimmun
diseas
yet
activ
molecul
limit
malaria
control
inflammatori
process
illustr
broadspectrum
activ
rang
bacteri
fungal
viral
infect
inde
due
toler
rare
toxic
report
inexpens
cost
immunomodulatori
properti
chloroquin
repurpos
explor
human
immunodefici
viru
hiv
virus
associ
inflamm
found
effici
inhibit
replic
cycl
recent
despit
drastic
contain
measur
spread
offici
known
sever
acut
respiratori
syndrom
coronaviru
ongo
phylogenet
analysi
viru
indic
differ
nucleotid
ident
relat
world
threaten
possibl
pandem
broadspectrum
antivir
effect
chloroquin
warrant
particular
attent
repurpos
drug
therapi
diseas
caus
name
coronaviru
diseas
vitro
chloroquin
appear
versatil
bioactiv
agent
report
possess
antivir
activ
rna
virus
divers
rabi
viru
polioviru
hiv
hepat
viru
hepat
c
viru
influenza
b
virus
influenza
viru
chikungunya
viru
dengu
viru
zika
viru
lassa
viru
hendra
nipah
virus
crimeancongo
hemorrhag
fever
viru
ebola
viru
well
variou
dna
virus
hepat
b
viru
herp
simplex
viru
antivir
properti
chloroquin
describ
vitro
sometim
confirm
treatment
virusinfect
patient
alway
reproduc
clinic
trial
depend
diseas
concentr
chloroquin
use
durat
treatment
clinic
team
charg
trial
regard
coronavirus
potenti
therapeut
benefit
chloroquin
notabl
report
chloroquin
also
report
inhibit
vitro
replic
epitheli
lung
cell
cultur
report
lethal
infect
newborn
mice
coronaviru
could
avert
administ
chloroquin
mother
milk
vitro
experi
also
show
strong
antivir
effect
chloroquin
recombin
coronaviru
although
chloroquin
report
activ
middl
east
respiratori
syndrom
coronaviru
merscov
vitro
observ
remain
controversi
broad
spectrum
action
virus
includ
coronavirus
particularli
close
rel
coronaviru
cell
entri
occur
endolysosom
pathway
made
sens
situat
publichealth
emerg
absenc
known
effici
therapi
investig
possibl
effect
chloroquin
recent
paper
report
chloroquin
antivir
drug
remdesivir
inhibit
vitro
suggest
drug
assess
human
patient
suffer
recent
china
nation
center
biotechnolog
develop
indic
chloroquin
one
three
drug
promis
profil
new
coronaviru
caus
chloroquin
repurpos
investig
hospit
beij
central
china
hunan
provinc
south
china
guangdong
provinc
accord
preliminari
report
chines
author
suggest
approxim
infect
patient
treat
chloroquin
experienc
rapid
declin
fever
improv
lung
comput
tomographi
ct
imag
requir
shorter
time
recov
compar
control
group
obviou
seriou
advers
effect
chines
medic
advisori
board
suggest
chloroquin
inclus
treatment
guidelin
result
chloroquin
probabl
first
molecul
use
china
abroad
front
line
treatment
sever
infect
although
long
use
drug
malaria
therapi
demonstr
safeti
acut
chloroquin
administr
human
one
ignor
minor
risk
macular
retinopathi
depend
cumul
dose
exist
report
cardiomyopathi
sever
advers
effect
caus
chloroquin
survey
patient
advers
effect
chloroquin
therapi
remain
perform
howev
chloroquin
current
among
best
avail
candid
impact
sever
infect
human
current
least
ten
clinic
trial
test
chloroquin
therapi
chloroquin
multipl
mechan
action
may
differ
accord
pathogen
studi
chloroquin
inhibit
preentri
step
viral
cycl
interf
viral
particl
bind
cellular
cell
surfac
receptor
chloroquin
shown
inhibit
quinon
reductas
structur
neighbour
udpn
acetylglucosamin
involv
biosynthesi
sialic
acid
sialic
acid
acid
monosaccharid
found
extrem
sugar
chain
present
cell
transmembran
protein
critic
compon
ligand
recognit
possibl
interfer
chloroquin
sialic
acid
biosynthesi
could
account
broad
antivir
spectrum
drug
sinc
virus
human
coronaviru
orthomyxovirus
use
sialic
acid
moieti
receptor
potent
effect
chloroquin
vitro
consid
attribut
deficit
glycosyl
viru
cell
surfac
receptor
angiotensinconvert
enzym
vero
cell
chloroquin
also
impair
anoth
earli
stage
viru
replic
interf
phdepend
endosomemedi
viral
entri
envelop
virus
dengu
viru
chikungunya
viru
due
alkalis
endosom
chloroquin
effect
vitro
treatment
chikungunya
viru
ad
vero
cell
prior
viru
exposur
mechan
inhibit
like
involv
prevent
endocytosi
andor
rapid
elev
endosom
ph
abrog
virusendosom
fusion
phdepend
mechan
entri
coronaviru
target
cell
also
report
bind
dcsign
receptor
activ
step
occur
endosom
acid
ph
result
fusion
viral
endosom
membran
lead
releas
viral
genom
cytosol
absenc
antivir
drug
viru
target
lysosom
compart
low
ph
along
action
enzym
disrupt
viral
particl
thu
liber
infecti
nucleic
acid
sever
case
enzym
necessari
replic
chloroquinemedi
inhibit
hepat
viru
found
associ
uncoat
thu
block
entir
replic
cycl
chloroquin
also
interfer
posttransl
modif
viral
protein
posttransl
modif
involv
proteas
glycosyltransferas
occur
within
endoplasm
reticulum
transgolgi
network
vesicl
may
requir
low
ph
hiv
antiretrovir
effect
chloroquin
attribut
posttranscript
inhibit
glycosyl
envelop
glycoprotein
neosynthesis
e
accord
zhao
et
al
f
accord
vlasak
et
al
g
accord
huang
et
al
h
accord
chan
et
al
worth
note
differ
host
cell
proteas
requir
activ
spike
protein
coronavirus
protein
requir
activ
cathepsin
l
merscov
requir
furinmedi
activ
protein
viru
particl
noninfecti
chloroquin
also
inhibit
replic
viru
affect
normal
proteolyt
process
flaviviru
prm
protein
protein
result
viral
infect
impair
herp
simplex
viru
hsv
model
chloroquin
inhibit
bud
accumul
noninfecti
particl
transgolgi
network
use
nonhuman
coronaviru
shown
intracellular
site
coronaviru
bud
determin
localis
membran
protein
accumul
golgi
complex
beyond
site
virion
bud
suggest
possibl
action
chloroquin
step
replic
cycl
recent
report
ctermin
domain
merscov
protein
contain
transgolgi
network
localis
signal
besid
affect
viru
matur
process
ph
modul
chloroquin
impair
proper
matur
viral
protein
recognit
viral
antigen
dendrit
cell
occur
tolllik
receptordepend
pathway
requir
endosom
acidif
contrari
propos
effect
chloroquin
immun
system
includ
increas
export
solubl
antigen
cytosol
dendrit
cell
enhanc
human
cytotox
tcell
respons
viral
antigen
influenza
viru
model
report
chloroquin
improv
crosspresent
nonrepl
viru
antigen
dendrit
cell
tcell
recruit
lymph
node
drain
site
infect
elicit
broadli
protect
immun
respons
chloroquin
also
act
immun
system
cell
signal
regul
proinflammatori
cytokin
chloroquin
known
inhibit
phosphoryl
activ
mitogenactiv
protein
kinas
mapk
cell
well
activ
cell
via
mapk
signal
frequent
requir
virus
achiev
replic
cycl
model
coronaviru
chloroquineinduc
viru
inhibit
occur
inhibit
mapk
chloroquin
wellknown
immunomodulatori
agent
capabl
mediat
antiinflammatori
respons
therefor
clinic
applic
drug
inflammatori
diseas
rheumatoid
arthriti
lupu
erythematosu
sarcoidosi
chloroquin
inhibit
beta
mrna
express
cell
reduc
releas
chloroquineinduc
reduct
cytokin
also
found
monocytesmacrophag
chloroquineinduc
inhibit
tumour
necrosi
factoralpha
tnf
product
immun
cell
report
occur
either
disrupt
cellular
iron
metabol
blockad
convers
protnf
solubl
matur
tnf
molecul
andor
inhibit
tnf
mrna
express
inhibit
tnf
receptor
also
report
monocyt
cell
treat
chloroquin
dengu
viru
model
chloroquin
found
inhibit
interferonalpha
ifn
ifn
ifn
tnf
gene
express
cell
infect
viru
chloroquin
shown
capabl
inhibit
vitro
replic
sever
coronavirus
recent
public
support
hypothesi
chloroquin
improv
clinic
outcom
patient
infect
multipl
molecular
mechan
chloroquin
achiev
result
remain
explor
sinc
found
day
ago
utilis
cell
surfac
receptor
express
lung
heart
kidney
intestin
tabl
may
hypothesis
chloroquin
also
interfer
receptor
glycosyl
thu
prevent
bind
target
cell
wang
cheng
report
sarscov
merscov
upregul
express
lung
tissu
process
could
acceler
replic
spread
although
bind
sarscov
sialic
acid
report
far
expect
betacoronaviru
adapt
human
involv
progress
loss
hemagglutininesteras
lectin
activ
like
coronavirus
target
sialic
acid
cell
subtyp
interact
affect
chloroquin
treatment
today
preliminari
data
indic
chloroquin
interfer
attempt
acidifi
lysosom
presum
inhibit
cathepsin
requir
low
ph
optim
cleavag
spike
protein
prerequisit
format
autophagosom
obvious
hypothesis
molecular
crosstalk
target
cell
alter
chloroquin
inhibit
kinas
mapk
chloroquin
could
also
interfer
proteolyt
process
protein
alter
virion
assembl
bud
fig
glycoprotein
determin
host
tropism
indic
bind
angiotensinconvert
enzym
express
pneumocyt
bind
expect
trigger
conform
chang
glycoprotein
allow
cleavag
transmembran
proteas
protein
releas
fragment
cellular
supernat
inhibit
viru
neutralis
antibodi
viru
transport
cell
earli
late
endosom
host
proteas
cathepsin
l
cleav
protein
low
ph
lead
fusion
viral
envelop
phospholipid
membran
endosom
result
releas
viral
genom
cell
cytoplasm
replic
start
positivestrand
viral
genom
rna
transcrib
neg
rna
strand
use
templat
synthesi
viral
mrna
synthesi
neg
rna
strand
peak
earlier
fall
faster
synthesi
posit
strand
infect
cell
contain
time
posit
strand
neg
strand
ribosom
machineri
infect
cell
divert
favour
viru
synthesis
nonstructur
protein
nsp
assembl
replicasetranscriptas
complex
favour
viral
subgenom
mrna
synthesi
see
review
fehr
perlman
detail
follow
replic
envelop
protein
translat
insert
endoplasm
reticulum
move
golgi
compart
viral
genom
rna
packag
nucleocapsid
envelop
protein
incorpor
bud
step
form
matur
virion
protein
localis
transgolgi
network
play
essenti
role
viral
assembl
interact
protein
viru
follow
assembl
newli
form
viral
particl
transport
cell
surfac
vesicl
releas
exocytosi
possibl
chloroquin
interfer
receptor
glycosyl
thu
prevent
bind
target
cell
chloroquin
could
also
possibl
limit
biosynthesi
sialic
acid
may
requir
cell
surfac
bind
bind
viral
particl
achiev
chloroquin
may
modul
acidif
endosom
therebi
inhibit
format
autophagosom
reduct
cellular
mitogenactiv
protein
map
kinas
activ
chloroquin
may
also
inhibit
viru
replic
moreov
chloroquin
could
alter
protein
matur
interfer
virion
assembl
bud
respect
effect
chloroquin
immun
system
see
eleg
review
savarino
et
al
ergic
ergolgi
intermedi
compart
